Clinical Characteristics of Patients
. | IdCSA . | IdCSA + IdMTX . | P . |
---|---|---|---|
No. of patients | 28 | 32 | |
Age (y) | |||
Median (range) | 29 (14-43) | 30 (11-43) | NS-150 |
Recipient gender | |||
Male/female | 13/15 | 18/14 | NS-151 |
Donor age (y) | |||
Median (range) | 27 (15-47) | 30 (9-51) | NS-150 |
Donor gender | |||
Male/female | 16/12 | 14/18 | NS-150 |
Disease status | |||
CR1 | 23 | 26 | NS-151 |
>CR1 | 5 | 6 | NS-151 |
FAB classification | |||
M1-M2 | 13 | 14 | |
M3 | 7 | 6 | |
M4-M5 | 7 | 11 | |
M6 | 0 | 1 | |
M7 | 1 | 0 | |
Days from diagnosis to HSCT | |||
Median (range) | 183 (108-356) | 173 (58-542) | NS-150 |
No. of infused cells (×108/kg) | |||
Median (range) | 3.4 (1.5-10) | 4.5 (1.3-11) | .09-150 |
. | IdCSA . | IdCSA + IdMTX . | P . |
---|---|---|---|
No. of patients | 28 | 32 | |
Age (y) | |||
Median (range) | 29 (14-43) | 30 (11-43) | NS-150 |
Recipient gender | |||
Male/female | 13/15 | 18/14 | NS-151 |
Donor age (y) | |||
Median (range) | 27 (15-47) | 30 (9-51) | NS-150 |
Donor gender | |||
Male/female | 16/12 | 14/18 | NS-150 |
Disease status | |||
CR1 | 23 | 26 | NS-151 |
>CR1 | 5 | 6 | NS-151 |
FAB classification | |||
M1-M2 | 13 | 14 | |
M3 | 7 | 6 | |
M4-M5 | 7 | 11 | |
M6 | 0 | 1 | |
M7 | 1 | 0 | |
Days from diagnosis to HSCT | |||
Median (range) | 183 (108-356) | 173 (58-542) | NS-150 |
No. of infused cells (×108/kg) | |||
Median (range) | 3.4 (1.5-10) | 4.5 (1.3-11) | .09-150 |